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Highlights 17 
• Endocrine disruption is a very complex and critical public health issue 18 
• There is a need for human-relevant models to assess endocrine physiology and the physiology 19 
of period at risks 20 
• The sheep is a good alternative to classical rodent models to understand fetal exposure, thyroid 21 
disruption and its consequences on brain development 22 
• The sheep allows real-life exposure scenario to complex mixtures.  23 





There are many challenges to overcome in order to properly understand both the exposure to, and 27 
effects of, endocrine disruptors (EDs). This is particularly true with respect to fetal life where ED 28 
exposures are a major issue requiring toxicokinetic studies of materno-fetal exchange and 29 
identification of pathophysiological consequences. The sheep, a monotocous large size species is very 30 
suitable for in utero fetal catheterization allowing a modelling approach predictive of human fetal 31 
exposure. Predicting adverse effects of EDs on human health is frequently impeded by the wide 32 
interspecies differences in the regulation of endocrine functions and their effect on biological 33 
processes. Because of its similarity to humans as regards gestational and thyroid physiologies and 34 
brain ontogeny, the sheep constitutes a highly appropriate model to move one step further on thyroid 35 
disruptor hazard assessment. As a grazing animal, sheep has also been proven to be useful in the 36 
evaluation of the consequences of chronic environmental exposure to “real-life” complex mixtures at 37 
different stages of the reproductive life cycle.  38 
 39 
Key words: endocrine disruptors – sheep model –fetal exposure- thyroid - mixture 40 
  41 
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1.  INTRODUCTION  42 
Many in vitro/ex vivo tools have recently been developed and have proved t  be very useful for rapidly 43 
screening and/or understanding of the mechanisms of action of endocrine disruptors (EDs). However, 44 
the complexity and the diversity of the effects of EDs underline the need for integrated in vivo models 45 
based on the appropriate use of species relevant to human for hazard assessment. This is a prerequisite 46 
to minimise the levels of uncertainty when extrapolting from animal findings to human. Rodent 47 
models are extensively used in toxicology, including endocrine toxicology, and are considered as the 48 
reference species for regulatory toxicology purposes. These models have many advantages in terms of 49 
both study duration and feasibility. These include reasonable extrapolation of some representative 50 
functions to the human, complete genetic and molecular characterisation and affordable costs. Many 51 
experimental studies have demonstrated that low doses f common pollutants, such as BPA (bisphenol 52 
A), can disrupt endocrine function, brain development and reproduction (Heindel et al., 2015; Le 53 
Magueresse-Battistoni et al., 2018; Caporossi and Papaleo, 2017), 2017; Mhaouty-Kodja et al., 2018; 54 
Palanza et al., 2016; Viguié et al., 2018) in rodents xposed during intrauterine life. The rodent models 55 
have, thus, been successfully used in pioneering studies establishing the proof of concept for the 56 
existence of EDs and their related adverse effects on the health of individuals and/or their progeny. 57 
However, the process of extrapolating experimental animal data to the human, requires an additional 58 
step towards maximising the human-relevance of the diff rent models. This step must be based on an 59 
improved consideration of interspecies differences in the developmental and physiological scheme of 60 
regulation of endocrine functions. The challenges and questions paving the way toward a better 61 
understanding of ED effects are numerous and it is hardly conceivable that a single non-human species 62 
could enable the production of a precisely human-relevant picture for every physiological system and 63 
developmental stage. It would be a matter of grave concern, therefore, should the scientific community 64 
and the regulatory bodies rely solely on approaches exclusively designed in and for rodents.  65 
The existence of windows of sensitivity to ED actions that result in potentially adverse 66 
transgenerational effects is a critical issue and a challenge for the ED research field. The hormone 67 
dysregulating properties of EDs are of great importance if exposure occurs during early developmental 68 
stages. This is when hormones are exerting permanent eff cts on fetal development by interacting with 69 
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the in utero processes of biological functional programming (Catanese et al., 2015). Thus, the 70 
prediction of fetal exposure to ED is a major issue that should not be neglected. It is noteworthy that71 
such considerations are now being incorporated into some research funder priorities, as for example in 72 
the EU Horizon 2020 programmes around the exposome https://ec.europa.eu/info/funding-73 
tenders/opportunities/portal/screen/opportunities/topic-details/sc1-bhc-28-2019. Fetal development 74 
proceeds from complex multilevel interactions between the mother and the fetus. The great differences 75 
in gestational physiology and, above all, endocrine function, which exists between rodents and humans 76 
have led to serious concerns about extrapolating rodent data to humans (Habert et al., 2014). Sheep 77 
have long been used as an animal model for studying fetal physiology and much of the available 78 
information on maternal-fetal pharmacokinetic has been obtained from pregnant ewe (Szeto, 1982). 79 
Together with the fact that characterising fetal exposure is a critical issue in the field of EDs, these 80 
historical data prompted us to develop an in utero catheterised ovine fetus model (Meschia et al., 81 
1965) to determine bi-directional transplacental exchanges of bisphenol A (BPA) and its main 82 
metabolite BPA-glucuronide (BPA-G). It is noteworthy that the relevance of this model goes far 83 
beyond EDs since it is relevant to any contaminants for which fetal exposure is at high risk. This 84 
model enables maternal and fetal compartments to be ass ssed separately and allows direct fetal 85 
administration of EDs, thus by-passing maternal metabolism if required. We use this system to 86 
develop a pharmacokinetic-based modelling approach to predict the extent of human fetal tissue 87 
exposure to the active form of BPA and by comparison to BPS (Corbel et al., 2013; Gauderat et al., 88 
2017; Grandin et al., 2019, 2018).  89 
One major source of uncertainty when predicting the potential adverse effects of EDs on human 90 
health relies on coping with the considerable inter-species differences in the regulatory pathways and 91 
feedback loops of endocrine functions and their effect on critical biological processes. It is all themore 92 
worrying, therefore, that regulatory toxicological in vivo evaluations rely mainly on rodent studies. 93 
Thyroid disruption is an emblematic example of how the relevance of rodent results to humans can be 94 
debatable. We have come to the point when some of the in er-species differences in thyroid function 95 




Finally, one major challenge when investigating theoxicology of environmental contaminants 98 
concerns the identification of human-relevant exposure systems/models. This is rendered even more 99 
difficult by the fact that both human and animal populations are likely to be exposed to a multitude of 100 
contaminants at a time and at low doses. One approach is the use of sentinel species who share the 101 
human environment, as in a recent study comparing the effects of two EDs on dog and human sperm 102 
but these do not necessarily address complex mixtures (Sumner et al., 2019). One other possible key 103 
strategy to address this critical challenge is to expose the test animals to “real life mixture”. There is 104 
some debate among the scientific community on the precise criteria for a “real life mixture” and the 105 
correct approaches to address this question. Exposing animals through their “natural” environment is 106 
one very interesting option that cannot be conducted in rodents. Using grazing animals that can be 107 
“naturally” exposed through their environment due to their feeding behaviour has been successfully 108 
developed in the sheep, notwithstanding the digestiv  and metabolic differences posed by the rumen in 109 
the ovine.  110 
Considering the most human-relevant strategies to evaluate the health and developmental risks of 111 
EDs, our goal here is to show, using the sheep model as a proof of concept, how a non-rodent animal 112 
model can complete and, in some instances, validate cl ssical regulatory rodent studies. We chose 113 
three well documented examples from ovine ED studies to demonstrate how using non-rodent models 114 
can be very useful to answer to some of the main scientific challenges in the ED research field. More 115 
specifically, we addressed the questions of the chara terisation and/or prediction of exposure during 116 
fetal life one of the most sensitive life stages, the relevance of the model with respect to endocrine 117 
regulation through the thyroid function and the ability to set up long-term “real life” exposure studies. 118 
 119 
2. MODELING MATERNO-FETAL EXCHANGES OF TOXICANTS  120 
2.1. Fetal sheep to predict human fetal exposure to an endocrine disruptor from semi-121 
physiological toxicokinetic models: application to the assessment of fetal exposure to 122 
bisphenols 123 
Exposure to chemicals during prenatal life is a major concern for toxicologists. Fetal exposure to 124 
endocrine disruptors (EDs) during critical windows of development has repeatedly been suggested to 125 
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be involved in the onset of a variety of adverse biological effects, later in life, even when exposure 126 
occurs at low doses (Vandenberg et al., 2012). 127 
A sound interpretation of human health implications of ED exposure, based on toxicological 128 
studies carried out in animal models, requires to be a le to determine the human blood and/or urinary 129 
concentrations of biologically active compounds. These can be compared with the concentrations 130 
measured in test species that have responded adversely to exposure through the mother. Indeed, it is 131 
typically acknowledged that any adverse systemic effect of a compound is directly related to the 132 
plasma concentrations of its biologically active form/s. Such relationships more often follow a 133 
classical linear or monotonic pattern, but it should be noted that non-monotonic dose responses, which 134 
are very difficult to characterise, have been reported for many EDs. The biomonitoring data regarding 135 
the concentrations in human maternal, fetal, and neonatal fluids are of the utmost importance to 136 
provide a reliable foundation for the extrapolations of risks, from animal studies to humans. However, 137 
measuring fetal chemical concentrations is difficult in humans and very few measurements of EDs in 138 
the human fetal circulation have ever been made. Th quantification of low levels of xenobiotics is 139 
hampered when the molecule of interest is ubiquitous in the environment and/or in tissue/sample 140 
collection, processing and analytical devices as is the case for BPA (Ye et al., 2013). Hence, the high 141 
values of cord blood BPA concentrations (in the ng/ml range) reported in some human biomonitoring 142 
studies (Zhang et al., 2014) should not be included in the risk assessment of BPA due to possible 143 
contaminations specifically related to exposure during delivery or to post-exposure sample 144 
contamination (Dekant and Völkel, 2008). 145 
The glucuronidation of drugs constitutes a major pathw y of elimination and glucuronide 146 
metabolites have been detected in fetal plasma following maternal drug administration, as it is the case 147 
for BPA. Hence, toxicokinetic studies have shown that BPA glucuronide (BPAG) accumulates in the 148 
plasma of fetal sheep and monkeys following maternal administration (Corbel et al., 2013; Patterson et 149 
al., 2013; Viguié et al., 2013; Vom Saal et al., 2014). Due to their lack of estrogenicity (Matthews et 150 
al., 2001; Skledar et al., 2016), the systemic exposure to bisphenol conjugated metabolites is not taken 151 
into account for risk assessment purposes. However, in vitro studies suggest that BPA glucuronide 152 
may exert biological activities similar to (Boucher et al., 2015) or different from those of the parent 153 
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compound (Viñas et al., 2013). This highlights the n ed for experimental data to elucidate the 154 
maternal-fetal toxicokinetic behaviour of bisphenols and to provide precise time-dependent 155 
measurements of the plasma concentrations of both the parent and glucuronidated metabolites. These 156 
data are essential for interpreting human biomonitori g data and for the development of toxicokinetic 157 
models to predict the extent of human fetal internal exposure, under an appropriate scheme of dietary 158 
and environmental exposures. 159 
 160 
2.2. Choice of a relevant animal model: the sheep for studying maternal-fetal 161 
pharmacokinetics 162 
Pregnant ewes have been used extensively for translational research and have contributed to very 163 
important advances in prenatal human medicine (Morrison et al., 2018). Due to the large size of these 164 
animals, catheters can be surgically inserted and maintained in both the maternal and fetal vasculature. 165 
Hence the chronically catheterised fetal sheep provides a unique model that permits the serial 166 
sampling of maternal and fetal blood, as well as other fluids, after maternal or fetal administration 167 
(Rurak et al., 1991). This animal model has already been applied to evaluate the disposition of several 168 
drugs during the prenatal period (Kumar et al., 1997; Ngamprasertwong et al., 2016). Furthermore, 169 
considerable insight regarding nutrient profiles has been gained from investigations of nutrient 170 
exchange in pregnant sheep (Barry and Anthony, 2008) highlighting important physiological 171 
similarities between the sheep and human placental functions despite structural differences. Indeed, 172 
although the sheep synepitheliochorial placenta differs histologically from the human hemochorial 173 
placenta, the microarchitecture of the ovine cotyledon is structurally analogous to that of the human 174 
placenta (Barry and Anthony, 2008; Leiser et al., 1997; Morrison et al., 2018). 175 
Drug concentrations in fetal plasma result from a complex interplay between bidirectional placental 176 
clearances and fetal metabolism. For many drugs, in particular the most lipophilic and the low 177 
molecular ionized ones, the most important mechanism of transfer across the placenta is the passive 178 
diffusion. In this case, the extent of drug transport is dependent upon not only the physicochemical 179 
properties of the drugs but also maternal and fetalblood flows (Rurak et al., 1991). Relative to the fetal 180 
body weight, the blood flow in the umbilical vein ad artery is of the same order of magnitude in sheep 181 
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(12 L/h.kg; Faber and Green, 1972; Rudolph, 1985) as in humans (7 L/kg.h, (Clavero et al., 1973; 182 
Haugen et al., 2004), indicating that the flow-limited transfer of drugs across the placenta in sheep and 183 
humans should be comparable. Accordingly, uteroplacental blood flow at the end of pregnancy is quite 184 
well preserved between rabbit, rodents, macaque, sheep and human, when normalized by the placenta 185 
weight (Mourier et al., 2017). By contrast, there are important interspecies differences in active 186 
transport of molecules (Walker et al., 2017).  187 
It has been shown that fetal sheep, compared to adults, possess low levels of some UDP-188 
glucuronosyltransferases (UGT) genes and thus likely lower activity (Pretheeban et al., 2011), similar 189 
to humans (Burchell et al., 1989), suggesting a lower capacity of the metabolic pathways in which 190 
these enzymes are involved in fetuses. In agreement with this observation, the intrinsic clearance of 191 
BPA glucuronidation in near-term fetal sheep (120–135 days of gestation) is about 2-fold lower than 192 
that of adults, the latter being of the same order as in adult humans (Corbel et al., 2015). Since a 193 
significant fraction of venous umbilical flow, about 75% in humans and 50% in sheep, passes through 194 
the fetal liver before reaching the systemic circulation, some pre-systemic conjugation can occur 195 
between the maternal and fetal circulations in both the sheep and human fetus (Edelstone et al., 1978; 196 
Haugen et al., 2004).  197 
 198 
2.3. Toxicokinetic modelling of fetal exposure to bisphenol A 199 
Toxicokinetic studies of BPA have been performed using the chronically catheterised fetal sheep 200 
model to evaluate the time-course of BPA and BPAG concentrations in maternal and fetal plasma 201 
following maternal and fetal BPA or BPAG intravenous dosing (Corbel et al., 2014; Gauderat et al., 202 
2016). This approach was applied to determine the relative contributions of the different pathways 203 
controlling fetal exposure to BPA. The parameters estimated by the model are summarized in fig. 1 204 
right-hand panel. At the end of pregnancy, about 6% of the maternal BPA dose enters the fetal 205 
circulation, i.e. a dose relative to body weight equivalent to the maternal dose. The closeness of this 206 
value with that estimated at 3.1% in human, using ad ex-vivo model of perfused human placental 207 
cotyledon (Corbel et al., 2014), emphasizes the relvance of the sheep model for studying placental 208 
drug transfer. Most of the BPA entering the fetal circulation was rapidly eliminated, mainly through 209 
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the direct clearance of BPA from the fetus to the mother. This represented approximately 74% of the 210 
fetal clearance of BPA. The remaining part of fetal BPA clearance (26%) was accounted for by the 211 
fetal metabolism of BPA into BPAG. Although not the predominant mechanisms of BPA elimination, 212 
the fetal conjugation clearance of BPA was higher tan in the adult, despite the lower fetal expression 213 
of the UGTs involved in fetal BPA glucuronidation (Pretheeban et al., 2011). This high fetal 214 
conjugation clearance of BPA was responsible for a significant first-pass conjugation of BPA 215 
transferred from the mother to the fetus. The limited fetal to maternal transfer accounted for about only 216 
17% of the total BPAG output. Therefore, the eliminat on of BPAG trapped in the fetal compartment 217 
mainly involved BPAG hydrolysis (83%).  218 
A non-linear mixed effect model (NLMEM) was used tosimultaneously analyse these 219 
toxicokinetic data and build a semi-physiologically-based toxicokinetic model of feto-maternal BPA 220 
exchange (Gauderat et al., 2017). The semi-physiologically-based toxicokinetic model of feto-221 
maternal BPA toxicokinetic developed in sheep was then humanised (Gauderat et al., 2016), using 222 
toxicokinetic data obtained in adult humans via ingestion of a BPA (d6-BPA) labelled cookie. This 223 
enabled the prediction of BPA and BPAG concentration- me profiles in human maternal and fetal 224 
plasma. After a pattern of repeated maternal exposure to BPA that mimics dietary exposure to the 225 
average dose estimated by EFSA ((EFSA, 2015), 11.05 nmol/d for 70 kg body weight), the 226 
toxicokinetic model predicted human plasma concentrations of non-conjugated BPA fluctuating 227 
between 14 and 140 pg/L in the adult and between 11 and 23 pg/L in the fetus, i.e. well below some of 228 
the very high concentrations (several hundred ng/L) of unconjugated BPA in cord blood reported in 229 
some human biomonitoring studies (Gerona et al., 2013; Veiga-Lopez et al., 2015). The maternal 230 
plasma BPAG concentrations predicted by the toxicokinetic model fluctuated considerably (between 231 
1.6 and 40 ng/L) depending on the delay between measur ments and ingestion of BPA, while the 232 
mean BPAG-predicted concentrations in the plasma of the human fetus were relatively stable and in 233 
the order of 40 ng/L. The consistency of these predictions with measurements of BPAG (median 234 
values of 120 and 960 ng/L, (Gerona et al., 2013; Veiga-Lopez et al., 2015) or total BPA (mean value 235 
of 46 ng/L; (Yamamoto et al., 2016) in human cord blood again emphasises the relevance of the 236 




2.4. Toxicokinetics of bisphenol S  239 
Owing to serious concerns regarding BPA the adverse ffects of BPA on human health, it has been 240 
replaced by structural analogues, mainly bisphenol S (BPS, (Liao et al., 2012). The high prevalence of 241 
BPS in urine from a cohort of US adults (Ye et al.,2015), and its detection in human cord blood 242 
(Kolatorova et al., 2018), gives rise to the question of the level of risk for human health associated 243 
with prenatal exposure to this BPA analogue. Indeed, in vitro studies have shown that BPS binds the 244 
estrogen receptors (ER) α and β (Molina-Molina et al., 2013) and acts as an ER agonist with a weaker 245 
or equivalent potency to that of BPA (Kojima et al., 2019; Kuruto-Niwa et al., 2005; Rosenmai et al., 246 
2014). Although limited in number, in vivo studies have shown that prenatal exposure of mice to BPS 247 
alters mammary gland development (Tucker et al., 2018). There is currently a critical gap in 248 
knowledge about the extent to which the human, especially the fetus, is internally exposed to emerging 249 
bisphenols. The only available toxicokinetic study of BPS performed in adult humans (Oh et al., 2018) 250 
suggests that the toxicokinetic behaviour of BPS may differ from that of BPA and highlights the need 251 
for animal studies of BPS toxicokinetic to identify the underlying mechanisms of gestational exposure 252 
to BPS. 253 
The main metabolite of BPS formed in vivo is BPS glucuronide (BPSG, Le Fol et al., 2015). 254 
Toxicokinetic studies of BPS and its major metabolite, were carried out using a chronically 255 
catheterised fetal sheep model to evaluate the time-course of BPS and BPSG concentrations in 256 
maternal and fetal plasma following maternal and fetal BPS or BPSG intravenous dosing (Grandin et 257 
al., 2018). It was striking that the fraction of the maternal BPS dose transferred from mother to fetus 258 
(0.40%) was about ten times lower than that of BPA (Gauderat et al., 2017; fig.1). A limited placental 259 
passage of BPS has also been revealed using an ex-vivo model of the perfused human placental 260 
cotyledon model (Grandin et al., 2019). In this model, the materno-fetal clearance index (0.0852) was 261 
about 10-fold lower than that of BPA. In sheep, only 26% of the BPS dose entering the fetal blood 262 
against 74% for BPA (fig.1) were rapidly eliminated through its transfer into maternal blood. This 263 
result is in agreement with the higher efficiency of fetal to maternal transfer as compared to its 264 
maternal to fetal counterpart evidenced in the perfus d human placenta (Grandin et al., 2019). About 265 
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half of the remaining BPS (46%) was metabolised by the fetus into BPSG. The elimination of this 266 
BPSG from the fetal compartment required its hydrolysis, like that of most of the BPAG, due to a 267 
limited placental transfer. Our compartmental toxick netic model predicted that, despite a lower 268 
materno-fetal passage of BPS compared to BPA, the higher persistency of BPS in the fetal 269 
compartment leads to expected BPS concentrations in fetal plasma of the same order than that of BPA 270 
(Grandin et al., 2018).  271 
  272 
3.  INTERSPECIES DIFFERENCES IN ENDOCRINE REGULATION: THE 273 
EXAMPLE OF THE THYROID FUNCTION  274 
Although the basic mechanisms of endocrine regulation, in particular feedback mechanisms, are well 275 
preserved among vertebrates, there are interspecies differences in the pathways mediating those 276 
mechanisms. This raises concern about the relevance of animal models for human endocrinology and 277 
our capacity to extrapolate results from animal to human when dealing with EDs. The sheep is a human-278 
relevant model to elucidate the regulation of several ndocrine systems, including the somatotropic, 279 
corticotropic, reproductive and thyroid systems in terms of both physiological and exposed conditions 280 
(Dutour et al., 1997; Evans et al., 2016; Karsch and Battaglia, 2002; Puttabyatappa et al., 2019). 281 
Unfortunately, in sheep as in other species, the ED research field is, to a large part, limited to the282 
reproductive, metabolic and thyroid functions. The interest in thyroid function is justified by the 283 
relatively high incidence of thyroid dysfunctions in humans. Overall in Europe, there are around 200 284 
new cases of thyroid disease/100,000/year. This is highest for hypothyroidism at 127 new 285 
cases/100,000/year (for review see Garmendia Madariaga et al., 2014). Furthermore, epidemiological 286 
and meta-analysis studies indicate a high incidence of undiagnosed thyroid function abnormalities 287 
(Garmendia Madariaga et al., 2014), including in pregnant women (Andersen, 2019).  288 
The fact that neural development and associated behavioural and cognitive capacities can be altered 289 
in response to even mild thyroid disruption has reinforced the increasing ED research focus on thyroid 290 
disruption. A prevailing hypothesis is that exposure to chemical contaminants targeting thyroid function, 291 
during critical windows of sensitivity in terms of thyroid and/or neural development, might play a 292 
substantial role in the development of such disorders (Zoeller et al., 2002). The regulatory evaluation of 293 
12 
 
developmental toxicity of chemicals is based on specific guidelines. In mammals, despite ongoing 294 
debate on the relevance of rodent models toward human thyroid physiology, the only in vivo proposed 295 
OECD guidelines for thyroid are rodents screening assays (OECD series on testing & assessment, 2012, 296 
n°150, 524). Thyroid investigations in those tests are limited and are not specifically designed to 297 
identify thyroid disruption. They are included in male and female pubertal assays, described by US EPA 298 
(US EPA OPPTS 890 1450-1500), and other repeated doses t xicity assays (OECD TG 407, 416, 443). 299 
These are based on amphibian studies or, in mammals, on thyroid hormones (TH) and/or Thyroid 300 
Stimulating Hormone (TSH) measurement in rodents at a given time point, usually at termination with, 301 
in the best case, histological evaluation of the thyroid gland. The OECD guidelines for 28 and 90 day 302 
repeated adult rodent exposure studies stipulate: “lthough in the international evaluation of endocrine 303 
related endpoint a clear advantage for the determinatio  of TH or TSH could not be demonstrated, it 304 
may be helpful to retain to measure T3, T4 and TSH if there is an indication for an effect on the 305 
pituitary-thyroid axis. Definitive identification of thyroid-active chemicals is more reliable by 306 
histopathology analysis” https://www.oecd-ilibrary.org/environment/test-no-407-repeated-dose-28-day-307 
oral-toxicity-study-in-rodents_9789264070684-en.  308 
 309 
3.1. TH metabolisms and specific binding proteins 310 
All levels of regulation of thyroid function are potential targets for environmental contaminants (for311 
review see: (Howdeshell, 2002; Zoeller, 2010). However, one of the most frequently reported 312 
mechanisms of action concerns the hepatic metabolism of thyroid hormones (TH, fig. 2). This is 313 
essentially based on extensive experimental data in rodents. In animals as in humans, hepatic catabolism 314 
of TH is mainly via glucuronidation catalysed by hepatic microsomal enzymes from the UDP-315 
glucuronyltransferase (UGT) and or cytoplasmic sulphotransferase (SULT) families. TH can also be 316 
metabolised by deiodinase enzymes, leading to either inactivation as for example the transformation of 317 
T3 to the inactive metabolite rT3 or bioactivation f T4 into T3. About 80% of circulating T3 comes 318 
from hepatic deiodination of T4. Both conjugations and deiodination pathways can be targets of EDs but 319 
conjugation pathways are the most frequently investigated. 320 
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Among factors contributing to the inter-specific differences in hepatic TH metabolism, plasma 321 
transport proteins of high specificity and affinity for TH namely thyroxin binding globulin (TBG) and 322 
transthyretin (TTR), are at the heart of the controve sy over the relevance of rodent models to humans. 323 
These proteins are common targets of several EDs. For example, data from biosensor assays have 324 
indicated the potent binding by hydroxylated metabolites of the polybrominated diphenyl ethers 325 
(PBDEs), BDE47, 49 and 99 to human TBG (Marchesini et al., 2008). The same biosensor assay 326 
confirmed the binding capacity of TTR for hydroxylated metabolites of PCBs and PBDEs, halogenated 327 
BPA and genistein. The expression profiles of these proteins differ markedly between the adult rodent 328 
and humans. The main difference lies in the level of expression of TBG, the protein with the highest 329 
affinity and specificity for thyroxine. It is indeed strongly expressed in humans, although subject to 330 
some variations in expression according to the physiological status. TBG is only expressed at very low331 
levels in the adult rat, but at higher levels in very young animals or aged individuals (Larsson et al., 332 
1985; Mendel et al., 1987; Savu et al., 1991). The diff rences in half-life and/or clearance of thyroxine 333 
are frequently attributed to the expression profile of TBG, which is thought to be involved in decreasing 334 
the accessibility of circulating TH to hepatocytes, thereby limiting the catabolism of these hormones. 335 
These differences in the pattern of plasma TH binding proteins often lead to the assumption that rats are 336 
more sensitive than humans to thyroid disruption proceeding from an increased hepatic catabolism of 337 
TH and are used as an argument to refute the results obtained in rodents. For example, the effects of 338 
both the insecticide fipronil (European Food Safety Authority (European Food Safety Authority 339 
(EFSA), 2006) and the no-phthalate alternative plasticizer 1,2-Cyclohexane Dicarboxylic Acid, Di-340 
Isononyl Ester (DINCH, (Bhat et al., 2014) on thyroid function were considered as not relevant to 341 
human during the course of their regulatory evaluation based on the interspecies difference in TBG 342 
expression. Interestingly, the profile of expression and pharmacodynamics properties of these proteins 343 
are very similar between human and sheep (fig. 3).  344 
It is noteworthy, that, at the level of the EU the revised guidance for the identification of EDs states 345 
that, “so long as not demonstrated as totally irrelevant to human, all results in rodents showing an effect 346 
of a xenobiotic on TH metabolism should be considere  as relevant to humans” (European Chemical 347 
Agency (ECHA) and European Food Safety Authority (EFSA) with the technical support of the Joint 348 
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Research Centre (JRC) et al., 2018). It remains true anyway that, to date, it is unclear to what extent 349 
inducible UGT/SULT expression and activity can mediate disturbances of TH catabolism in humans. 350 
The ECHA recommendation for a better consideration of rodent data for the evaluation of potential 351 
thyroid disruptors can thus be viewed like a precautionary measure in face of the uncertainties related to 352 
the human-relevance of animal models for this particular mechanism.  353 
The induction of enzyme pathways involved in thyroid metabolism is often mediated through the 354 
activation of Xenobiotic Nuclear receptors (XNRs; (Kretschmer and Baldwin, 2005) and is not strictly 355 
specific of thyroid hormones. Most of these receptors exhibit wide interspecies differences in their 356 
pharmacological properties (Gibson et al., 2002; Jones et al., 2000). It is therefore very difficult to 357 
predict the hepatic inductive properties of xenobiotics in humans on the basis of data collected in 358 
rodents. Our work on thyroid disruption in response to fipronil provides a good example of how 359 
interspecies differences render dealing with the issue of the relevance of animal models toward human 360 
so difficult when looking at TH hepatic catabolism. The effect of the insecticide fipronil and/or its much 361 
more persistent metabolite, fipronil sulphone, on thyroid function has been well established in the rat. 362 
Both fipronil and its main metabolite fipronil sulphone treatments increase T4 clearance jointly to liver 363 
UGT activity in the rat (Leghait et al., 2009; Roques et al., 2012). In the sheep, a species expressing a 364 
very similar TBG to that of humans, the effect of fipronil exposure on thyroid homeostasis is much 365 
more limited (Leghait et al., 2010). However, it cannot be assumed at this point that these differences 366 
are solely related to different patterns of TBG expr ssion. Pertinently, the rate of metabolic conversion 367 
of fipronil into its bioactive persistent metabolite,fipronil sulphone, differs markedly between the two 368 
species (Leghait et al., 2010) indicating differential effects on the induction of the hepatic cytochrome 369 
enzymes involved in fipronil metabolism. Fipronil sulphone is much more persistent than fipronil itself 370 
and at least as active as fipronil to increase TH hepatic catabolism. In the rat, fipronil treatment led to 371 
the upregulation of several genes involved in the metabolism of xenobiotics and or TH, including the 372 
cytochrome P450 Cyp2b1, Cyp2b2 and Cyp3a1, the carboxylesterases Ces2 and Ces6, the phase II 373 
enzymes Ugt1a1, Sult1b1 and Gsta2, and the membrane t sporters Abcc2, Abcc3, Abcg5, Abcg8, 374 
Slco1a1 and Slco1a4. Our data in CAR- or PXR-invalidated mouse indicate that PXR and CAR are 375 
mediating, at least in part, the fipronil-induced upregulation  of the expression of enzyme/transporter 376 
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genes (Roques et al., 2013) which, in rats, may contribute to increase thyroid hormone clearance. Given 377 
the wide interspecies differences in XNRs pharmacology, it is impossible at this point to determine if 378 
the difference in response to fipronil between the two species, in terms of thyroid disruption, is due to 379 
differential expression of TBG or to differences in XNR receptor affinities for fipronil or its metabolite 380 
or both. Although the sheep can be considered much more relevant to human than rodent from the 381 
standpoint of specific TH binding proteins, the relevance of this model to human in terms of the effect 382 
of fipronil on thyroid homeostasis is not currently certain.  383 
 384 
3.2. Thyroid-mediated alterations of brain development 385 
While the mode of action of EDs on thyroid function is much debated as regards hepatic initiating 386 
events, the evaluation of the adverse effects of subtle thyroid disruption is a real matter of complexity. 387 
One of the most, if not the most, challenging and worrying adverse effect of thyroid disruptors is the388 
potential alteration of the development of the central nervous system (CNS) and resulting behavioural 389 
and cognitive deficiencies even with moderate thyroid disruption as with isolated hypothyroxinemia 390 
(Bellanger et al., 2015; Ghassabian et al., 2014; Gilbert et al., 2012a; Howdeshell, 2002). The proof f 391 
concept for linking subtle perinatal thyroid disruption, alterations of the CNS and related-cognitive 392 
deficiencies has been efficiently established in rodents, but the process still needs to be taken one step 393 
further, with integrated complementary models more relevant than rodents as regards human 394 
physiology. The period of gestation is a window of high vulnerability to perturbed thyroid function 395 
and, consequently, for developing tissues and functio s which are under the control of TH. During this 396 
period, the mothers have to face increased TH requiments due to the fact that their own metabolic 397 
rate is increased to maintain a normal gestation. In addition, the needs of the fetus, particularly at early 398 
developmental stages when the fetal thyroid system is not yet functional, adds to this burden. Thus, 399 
pregnancy involves profound changes in almost all aspects of thyroid regulation. For example, the 400 
increase in TH production rate to satisfy gestationl demand is estimated at about 50% of the basal 401 
rate. The maintenance of normal thyroid function is strictly dependent upon iodine supply and/or 402 
turnover. During gestation, urinary elimination of i dine is increased because of a higher glomerular 403 
filtration rate, which itself constitutes another susceptibility factor of thyroid function. In both human 404 
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and sheep, total serum T4 and T3 concentrations rise to levels higher than those of non-pregnant 405 
individuals. BPA is a good illustration on how a contaminant that does not seem to have any effect on 406 
the thyroid function of adult non-pregnant animals might affect this function in pregnant animals 407 
and/or their offspring. There are indeed data in both r dents and sheep showing that BPA can alter the 408 
thyroid function of pregnant animals and/or their offspring (Guignard et al., 2017; Silva et al., 2019; 409 
Viguié et al., 2013; Xu et al., 2019; Zoeller et al., 2005). 410 
The dependency of the fetus on TH maternal supply is particularly important at the early stages of 411 
the development (fig. 4). The fetal/ neonates thyroid function develops earlier in human and sheep 412 
than in rodents. Fetal thyroid function starts after th  first third of the pregnancy in human as well as in 413 
sheep (fig. 4) while it starts much later, in the last third of pregnancy in rodents (Fisher, 1991; Fisher 414 
et al., 1976; Howdeshell, 2002; Polk et al., 1991). Consequently, the window of sensitivity to thyroid 415 
disruption might differ between humans and rodents. The sheep might thus represent a better 416 
alternative than rodents when investigating the window of sensitivity during which an effect of thyroid 417 
disruption on CNS development will be established.  418 
In addition, the mode of exposure to contaminants differs between pre and post-natal life. During 419 
prenatal life, the exposure occurs from the mother rough the placental barrier that in some instances 420 
protects the fetus. During post-natal life, the exposure will occur via oral route through lactation. Thus, 421 
it is almost impossible to reproduce in rodents the same scheme of exposure to contaminants at the 422 
final stage of the thyroid maturation as in humans. I  addition to the effects of contaminants on the 423 
maternal thyroid function, there is evidence that domestic and/or environmental contaminant can 424 
disrupt the development of fetal thyroid. Maternal smoking and high maternal BMI are associated with 425 
disturbed fetal thyroid gland development and endocrine function in a sex-specific manner during the 426 
second trimester of pregnancy in humans (Filis et al., 2018). Similarly, peri-conceptional maternal 427 
exposure to sewage sludge chemicals impedes fetal thyroid gland development in the sheep 428 
(Hombach-Klonisch et al., 2013). BPA has also been shown to be a potential disruptor of maternal 429 
and/or fetal thyroid function following chronic high (5 mg/kg/day) or low (5 µg/kg/day) dose 430 
administration from the first to the last month of gestation in sheep (Guignard et al., 2017; Viguié et 431 
al., 2013). Interestingly, some, although not all, epidemiological dat from large human cohorts also 432 
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show a correlation between gestational BPA exposure and some degrees of thyroid disruption in 433 
newborns (Aung et al., 2017; Chevrier et al., 2013; Romano et al., 2015). 434 
The role of TH in brain development and homeostasis is well documented in animal experimental 435 
models (Howdeshell, 2002) including for subtle thyroid disruption. In the human, although the effect 436 
of moderate thyroid disruption on behaviour and cognitive function development is still debated, some 437 
epidemiological studies suggest a potential link betwe n maternal hypothyroxinemia (decreased free-438 
T4 concentration with or without modifications of TSH) during pregnancy and increased risk of 439 
autism, impaired psychomotor development, Attention Deficit Hyperactivity Disorder, delay in 440 
language development and lower mental scores (for review: (Henrichs et al., 2013). The overall costs 441 
of such alterations in relation to ED exposures have been estimated at approximately 150 billions € 442 
/year in the EU (Trasande et al., 2015). In the mouse, a 36% decrease in maternal T4 concentrations 443 
without any modification of circulating T3 from gestational day (GD) 10 to GD13 is associated with a 444 
cellular and molecular environment in the cortex that is unfavourable to neuronal migration (Cuevas et 445 
al., 2005). In the rat, different models of chemically-induced moderate thyroid disruption during 446 
pregnancy (e.g. iodine deficiency, perchlorate exposure, propylthiouracil) consistently show that these 447 
manipulations are associated with functional modifications within the hippocampus with an alteration 448 
of synaptic functions that can last until the adult stage even after a full recovery of the thyroid function 449 
(Gilbert et al., 2017, 2012b; Gilbert and Sui, 2006). Subcortical band heterotopia (SBH) represent a 450 
neuronal migration error in humans. In rats, even mi or (<15%) reductions in maternal serum 451 
thyroxine is associated with increased volume and presence of SBH in the corpus callosum of 452 
offspring that persists in adulthood (Gilbert et al., 2014). In rodent models, as in humans, this 453 
abnormality in brain development is associated with serious adverse neurological and/or behavioural 454 
effects. The whole process of SBH development starts in the periventricular area i.e in close vicinity to 455 
major sources of TH supply to the brain, the cerebrospinal fluid and vasculature.  456 
Taken together, there is considerable rodent model evidence for the adverse effects of ED-induced 457 
mild thyroid disruption in CNS development and potential mechanisms of action ((Gilbert and Lasley, 458 
2013; Mughal et al., 2018; Remaud et al., 2014; Zoeller et al., 2002). However, the interspecies 459 
temporal differences in the development of thyroid function, and of the CNS itself, emphasizes the 460 
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need for other animal models more relevant to human. This is especially important for the 461 
determination of the critical windows of action of EDs in the brain, neurocognitive and behavioural 462 
functions. From this standpoint, the sheep is an excellent model (Back and Hohimer, 2016), meeting 463 
several critical criteria: i) being a reference model for physiology of gestation and development 464 
(Morrison et al., 2018), ii) having similar regulation of thyroid function to that of human , iii) 465 
exhibiting time-lines for the synchronised development of the thyroid and CNS that are similar to 466 
human (fig. 4), iv) possessing considerable homology with human brain anatomy (gyrencephalic 467 
species (Vink, 2018) and maturation (a marked difference with lissencephalic species like the mouse). 468 
This makes the ovine model very valuable for the study of neurodevelopmental diseases and/or 469 
alteration in the pattern of brain development.  470 
Overall, it is clear that regulatory studies of thyroid disruption are limited due to both the use of 471 
reference species which are controversial in terms of their relevance to human and the use of terminal 472 
endpoints and periods of observation that might only partially reflect the thyroid status of the animals 473 
and/or developmental exposure. There are very few recommendations for using other models than 474 
rodents and therefore very few data for a proper evaluation of interspecies differences, that could serve 475 
as a base for a sound extrapolation of experimental a imal data to human.  476 
 477 
4. A HERBIVORE AT THE INTERFACE BETWEEN ENVIRONMENTAL 478 
POLLUTANT AND PHYSIOLOGICAL EFFECT: A MODEL FIT FOR REAL 479 
LIFE SCENARIO EXPOSURE  480 
The banning of disposal of human sewage into the seas and oceans by the EU in 1997 hastened the 481 
development of alternatives for the repurposing and processing of this waste material. Human sewage 482 
has long been used as a fertiliser (called “night soil”) and this trend has continued with the 483 
employment of processed, dried, human sewage as a fertiliser. Subsequently, agricultural usage laws 484 
and guidelines have been imposed. Sewage sludge is, of course, an exquisite read-out of combined 485 
man-made and environmentally distributed pollution, including a rich cocktail of EDs. The Aberdeen 486 
sewage sludge model, using outbred sheep, was established by Dr Stewart M. Rhind (deceased) at the 487 
James Hutton Institute (previously the Macaulay Institute) and has been previously reviewed (Evans et 488 
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al., 2014; Fowler et al., 2012; Rhind et al., 2010a) These reviews present considerable support for the 489 
use of sheep as a sentinel species for environmental ED effects throughout the life-course, with the 490 
added issue that, of course, sheep meat enters the human food chain. This issue has attracted 491 
considerable attention from both farming organisations and those opposed to the use of sewage sludge 492 
fertiliser. 493 
Here we present an update that hasresulted from some 20 years of research with extensiv  support 494 
from a range of organisations including the European Commission via the REEF project. Three main 495 
study designs have been employed in terms of the exposure paradigms via different fertilisers applied 496 
to pastures and these are summarised in fig. 5. In all three approaches fetal and maternal tissues have497 
been harvested, typically at 80, 110 or 140 days of gestation and offspring tissues in early adulthood at 498 
around 18 months. The simplest model has been the Always exposure profile where mother, gestation 499 
and offspring remain exposed to a single condition. These are Control fertilised, using inorganic 500 
fertiliser balanced for nitrogen content and Sewage Sludge fertilised, using processed, dried, human 501 
sewage sludge according to agricultural guidelines at the time. The next model was the Cross-over 502 
exposure profile. In this model the ewes were either moved to the opposing fertiliser regime (or not, t  503 
provide additional controls) and they and their offspring then remained on that pasture type until tissue 504 
harvesting at 110 days and 18 months post-natal. The model used in the REEF project was the 505 
Windows exposure profile. In this model the main study contr ls were animals reflecting both 506 
treatment conditions of the Always profile, matched with ewes exposed in early (0-80 days), mid (30-507 
110 days) and late (60-140 days) gestational windows and tissues harvested at 80 and 140 days. This 508 
design aimed to determine whether there were specific developmental windows of fetal sensitivity to 509 
EDs in sewage sludge. 510 
The results from these three study designs are summarised in fig. 6 and demonstrated the wide 511 
range of adverse consequences from pre- and post- natal exposure to low dose, complex, mixtures of 512 
EDs in sheep. 513 
 514 
4.1. Environmental and sheep tissue consequences of sewage sludge exposure 515 
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Unsurprisingly, sewage sludge pellets themselves contain considerably higher concentrations of 33 516 
EDs (including DEHP, PCBs, PBDEs, PAHs) measured and reported across 3 studies (Lind et al., 517 
2009a; Rhind et al., 2010b). The review from Evans (Evans et al., 2014) extensively assessed tissue 518 
and soil ED levels following sewage sludge application. 519 
EDs that were detectable in soil after sewage sludge application included phthalates, alkyphenols, 520 
PAHs, PCBs, PBDEs and DEHPs. However, accumulation of EDs in soil from pastures treated with 521 
sewage sludge fertiliser was highly variable across multiple studies, temporally and geographically 522 
changing with considerable differences in accumulation of specific EDs (Rhind et al., 2002; Zhang et 523 
al., 2014) and frequently at levels that in animal studies would be considered as No Observed Adverse 524 
Effect levels (NOAEL). For any single study, therefor , accurately predicting ED load taken up by 525 
grazing animals after sewage sludge application or extrapolating more widely, is difficult. Multiple 526 
applications of sewage sludge lead to increased concentrations of chemicals and the number of 527 
congeners (PBDEs) measurable (Rhind et al., 2013) but the magnitude of the increase is lower than 528 
expected from the total sewage sludge quantities usd on the pastures. An obvious explanation is that 529 
degradation or flushing of chemicals from sewage sludge-treated pasture will reduce animal exposure 530 
levels. Furthermore, since these EDs are in the environment from other sources, control pastures also 531 
contained detectable levels of many of them, althoug  sually at lower levels than seen in the sewage 532 
sludge fertilised pastures. Relevantly for BPA, while levels in soils were initially similar between 533 
control and sewage sludge pastures, the accumulation of this compound over 13 years of application 534 
was considerable, rising from 3 to 63 ng BPA/g of soil (Zhang et al., 2015). Furthermore, there was 535 
significant uptake by crops with up to 68 ng BPA/g of leafy vegetables. 536 
Tissue concentrations of EDs also displayed considerabl  variability. These ED concentrations can 537 
be influenced by the metabolic status of the animal and environmental contribution to routes of 538 
exposures, including ingestion and inhalation.  Therel ase of many lipophilic EDs from adipose stores 539 
when energy demands increase during gestation, means ED exposures are likely to be quite different 540 
between a dam and the fetus.  Of the EDs of interest in the sewage sludge studies, tissue levels of  541 
PCBs, PBDEs, PAHs, alkyl phenols and phthalates are v iously measurable in tissue and/or milk 542 
samples, collected from mothers, fetuses and lambs aintained on both the control and biosolids 543 
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treated pastures (Rhind et al., 2005, 2007, 2009, 210b, 2011a) with up to 30% variation in 544 
background tissue ED accumulation across Scotland (Rhind et al., 2011b) Overall, maternal and fetal 545 
tissue levels in kidney fat, muscle and liver were l vated, even if relatively modestly and variably 546 
following sewage sludge exposure in these studies. Furthermore, while many EDs are lipophilic, even 547 
during lactation, lamb ED levels were not markedly e evated compared to the dams (Rhind et al., 548 
2007). Different EDs also showed considerable variability between mothers and offspring and 549 
between studies. Tissue concentrations in 6 month old lambs on either treated or control pastures, 550 
showed a broadly similar pattern of tissue EDC concentrations to those seen in the adult ewes.  551 
Overall, fetal EDC concentrations and thus EDC exposure may be greater in early gestation as a 552 
result of lower detoxification capacity of the fetal liver (Rhind et al., 2010b). In studies where 553 
exposures of the ewes at conception or during gestation were altered (Cross-over and Windows 554 
studies) different outcomes were observed. In the former, there were almost no differences between 555 
control and cross-over animal tissue ED burdens (Rhind et al., 2010b). In the Windows study (Lea et 556 
al., 2016), soil PAH, DEHP and PCB levels were increased by sewage sludge exposure. In dams 10 of 557 
the 15 EDs that showed significant association with sewage sludge exposure were elevated, especially 558 
in the mid and late exposure windows although changes in fetal ED burdens were highly variable. 559 
Finally, we recently showed a sex difference in 18 month old sewage sludge exposed offspring, with 560 
higher liver PAHs and lower PCBs in males than femal s. Furthermore, PAHs were elevated and 561 
PCBs lowered in sewage sludge-exposed females compared to controls (Filis et al., 2019). 562 
 563 
4.2. Gonad and endocrine development 564 
While most of our reproductive studies focused more n the female, Always exposed 110 days of 565 
gestation male fetuses exhibited a wide range of significant developmental defects, including reduced 566 
circulating inhibin A, testosterone (nearly halved), Leydig and Sertoli cell numbers, body and testis 567 
weights (Paul et al., 2005). A programme of analysis of the fetal ovary spanned Always, Cross-over 568 
and Windows studies. There was some variability between the studies, for instance in the Always 569 
(Fowler et al., 2008) and Windows (Lea et al., 2016) studies fetal ovarian weight was not altered while 570 
sewage sludge exposed fetal ovaries were heavier in the Cross-over study (Bellingham et al., 2013) in 571 
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fetuses whose mothers remained on sewage sludge-fertilised pastures but not in those whose mothers 572 
switched pasture type at conception. Fetal circulating prolactin and estradiol levels were reduced and 573 
FSH unaffected in Always study exposed fetuses while inhibin A and FSH was increased and estradiol 574 
decreased in animals constantly exposed to sewage sludge in the Cross-over study. In the Windows 575 
study, clear signs of some virilisation were seen, with reduced uterine weight and increased anogenital 576 
distance in the late window of fetal sewage sludge exposure in particular, even though fetal 577 
testosterone was unaltered in this group.  578 
In terms of ovarian morphology, histological analysis howed that oocyte density was reduced in 579 
fetuses exposed to sewage sludge pasture (Always study, Fowler et al., 2008) with a shifted balance 580 
between the pro- (BCL2) and anti- (BAX) apoptotic ovarian markers. In the Cross-over study 581 
(Bellingham et al., 2013) in contrast, the only observed effect on follicle numbers was a reduction in 582 
the number of type 1a follicles in the fetuses whose mothers had been moved to sewage sludge 583 
pastures at mating. This was despite alterations in ovarian expression of a number of proteins/genes 584 
associated with follicle recruitment, activation, apoptosis and health. Subsequently, in the Windows 585 
study (Lea et al., 2016) there were several changes in numbers of different follicle classes, most 586 
notably a decrease in healthy and increase in atretic type 1a follicles in all exposed groups and 587 
indications of delayed follicle development ovaries from fetuses in the late exposure window. These 588 
changes were associated with a large number of proteome and transcriptome changes in the mid and 589 
late sewage sludge-exposed ovaries in particular. From these data network analyses predicted 590 
methylation associated changes were occurring in these 2 groups. 591 
 592 
4.3. Brain, pituitary and thyroid development and function 593 
Expression of GnRH and its receptor (Bellingham et al., 2010) and afferent systems to the GnRH 594 
neuronal network including Kisspeptin (Kiss-1)/GPR54, estradiol receptor alpha (ERα) (Bellingham 595 
et al., 2009), galanin and its receptors (Bellingham et al., 2010, 2009) within the hypothalamus and 596 
LHβ, Kisspeptin and ERα in the pituitary gland were affected in the sewage sludge-exposed fetuses, 597 
unlike their mothers (Always exposure model). GnRH and GnRH receptor mRNA concentrations were 598 
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reduced in the hypothalamus but unaffected in the pituitary glands of fetuses exposed to sewage 599 
sludge (Bellingham et al., 2010). Important steroid sensitive afferents to the GnRH neurosecretory 600 
system, galanin and kisspeptin were disrupted in fetuses exposed to sewage sludge: expression of 601 
KISS1 transcript and the three galanin receptor subtypes (1, 2 and 3) in both the hypothalamus and 602 
pituitary glands were reduced following maternal sewage sludge exposure. Estradiol receptor 603 
transcript expression within the hypothalamus and pituitary gland were not affected by sewage sludge 604 
exposure in either the mothers or their 110 day old fetuses. However, fetal pituitary ERα protein 605 
expression was reduced in sewage sludge-exposed fetuses. A similar range of endpoints were assessed 606 
in further study using the Cross-over study model (Bellingham et al., 2016). Fetal plasm FSH, 607 
estradiol and inhibin A were affected by sewage sludge exposure while LH and estradiol, but not 608 
testosterone, were affected in males. The direction of disruption varied according to exposure type: 609 
constant or cross-over, with sex-specific consequences. Overall, fetuses from mothers whose exposure 610 
type changed at mating showed more extensively disrupted hypothalamic and pituitary expression 611 
patterns of neuroendocrine regulators, such as the GnRH and Kisspeptin systems, than fetuses 612 
constantly exposed to sewage sludge. Male fetuses were more affected than females and exhibited 613 
more female-like patterns of neuroendocrine gene expression. Finally, 5 month old lambs were 614 
assessed using behavioural tests indicative of emotional reactivity and exploratory behaviour. Sewage 615 
sludge exposure in utero and post-natally was associated with a decrease in emotional reactivity and 616 
decreased activity levels. Furthermore, the exploratory behaviour of females was unaltered but that of 617 
males increased to match female levels (Erhard and Rhind, 2004). This shows that early exposure to 618 
low levels of a cocktail of pollutants, alters brain development and dimorphism that could have long-619 
term detrimental effects on reproductive behaviour. 620 
The fetal thyroid gland was also investigated in the Cross-over study (Hombach-Klonisch et al., 621 
2013). Fetal thyroid gland weight was only affected in the group moved from sewage sludge to control 622 
pastures at mating group.  Similarly, fetal blood thyroid hormone levels were not affected by 623 
treatment. In terms of fetal thyroid morphology, changing either from or to sewage sludge-treated 624 
pasture at mating was associated with a reduction in the number of thyroid follicles. Variable effects 625 
were observed in terms of blood vessel number, together with areas of immature thyroid follicle 626 
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development, reduced NIS (sodium-iodide-symporter) expression and focal lack of mature angio-627 
follicular differentiation in continuously exposed group fetal females and sewage sludge moved to 628 
control group fetal males being most affected. In co trast, in the Windows study (Lea et al., 2016), 629 
fetal thyroid weight was reduced in the late exposure window, together with reduced free T3 and 630 
increased free T4 in the same group.  631 
 632 
4.4. Adverse consequences of sewage sludge exposure in adulthood (18 months) 633 
Fetal and post-natal sewage sludge exposure affected male lamb bones more than the females (12/23 634 
bone parameters significantly different in males vs 2/23 parameters affected in females). In general, 635 
the bones of sewage sludge-exposed animals were mor fragile compared to the controls (Lind et al., 636 
2009b). In contrast, fetal bones were markedly lessaffected by the EDs present in sewage sludge 637 
pastures, unlike their mothers who showed reduced mineralisation and cross-sectional areas of some 638 
bones (Lind et al., 2010). 639 
Testes from in utero and post-natally sewage sludge-exposed rams were analysed at age 18 months 640 
old (Bellingham et al., 2012) and although there was no effect on mean testis weights, a subset of 641 
exposed rams had markedly lighter testes. While there were no differences in total mean number of 642 
germ cells, 42% of the exposed rams had total number of germ cells were lower than the minimum 643 
numbers in the control group. When this subgroup was analysed separately the number of germ cells 644 
per testes, germ cells per Sertoli cell, germ cell absolute volume, number of round spermatids, number 645 
of spermatocyctes were all reduced by sewage sludge exposure. They also exhibited an increase in 646 
tubule number, number of tubules with dilated lumens a d an increase in Sertoli cell only tubules 647 
which lacked germ cells in the testes collected from biosolids exposed animals. The sewage sludge-648 
exposed rams with small testes also had lowered FSH. While the in utero + post-natally exposed adult 649 
animals (Bellingham et al., 2012) showed different consequences of sewage sludge-exposure than the 650 
in utero exposed fetuses (Paul et al., 2005), changes observed in both studies, especially the reduction 651 
in the number of fetal Sertoli cells and adult Sertoli cell-only tubules and the reduction in germ cells in 652 
a subset of the adults, would disrupt sperm producing apacity. Analysis of ovaries from our study of 653 
in utero + post-natally sewage exposed 18 month old ewes has not currently been published. However, 654 
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(Fowler, personal communication), the consequences of the sewage sludge exposure include adverse 655 
morphological and molecular markers of ovarian function and health. One striking aspect is the 656 
retention of some fetal ovarian characteristics in the sewage sludge-exposed group. 657 
In Filis et al. (Filis et a., 2019), we investigated the livers from the adult animals discussed in the 658 
preceding paragraph. These animals exhibited sexually dimorphic patterns of ED burdens as discussed 659 
at the start of this section. The life-long sewage sludge-exposure of these animals manifested as altered 660 
xenobiotic and detoxification responses. The liver proteomes of both sexes were disrupted by sewage 661 
sludge exposure and proteins with altered expression pr files included major plasma-secreted and 662 
blood proteins, and metabolic enzymes. Pathway analysis predicted dysregulation of cancer-related 663 
pathways and altered lipid dynamics. Follow-up confirmed these predictions, with a reduction in total 664 
lipids in female livers and up-regulation of cancer related transcript markers in male livers respectiv ly 665 
by sewage sludge exposure. 666 
To draw together the sheep sewage sludge model section, this complex picture of highly variable 667 
and sometimes inconsistent changes in ED levels in the animals are reminiscent of the data held in 668 
human exposure cohorts, such as NHANES (National Health & Nutrition Survey: 669 
https://www.cdc.gov/nchs/nhanes/index.htm). In addition, this variable ED exposure profile is highly 670 
likely to contribute to the variable tissue- and sex- specific morphological, endocrine and molecular 671 
marker alterations observed in the sewage sludge expos d fetuses and adult offspring. In many ways 672 
this variability is very similar to data seen in human studies. 673 
 674 
5. CONCLUSION 675 
The complexity of the regulatory pathways triggered by EDs underlines the need for the identification 676 
of systemic biomarkers that can be robustly linked to ED exposures with minimal possible uncertainty. 677 
Choosing the right model is one of the best ways to reduce uncertainties. Rodents have proven to be 678 
very useful in evidencing the potential of chemicals to induce endocrine disruption and to provide data 679 
on their potential mechanisms of action and associated dverse effects. However, because the endocrine 680 
system is very plastic, it is clear that it is necessary to integrate the notion of interspecies differences 681 
into our way of thinking with respect to EDs. Sheep studies have clearly established that non-rodent 682 
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mammalian models contribute strongly to a better understanding of human health risk assessment than 683 
necessarily achieved using classical rodent studies. It should be acknowledged however, that like every 684 
other model, the large animal models, including sheep, also exhibit some limitations. Many of these 685 
limitations are practical, reflecting the need for large scale animal facilities. Sheep have long gestation 686 
lengths, making them more similar to human from the standpoint of duration of exposure and usually 687 
the timelines of ontogenesis. The price to pay, however, is that experiments can take years to complete. 688 
Sheep are, therefore, not suitable for rapid screening studies. Sheep placentation has some differences 689 
from the human and may not accurately predict human fetal exposure. However, the rodent placenta is 690 
not any better from this point of view and rodent models also do not allow kinetic investigations 691 
required for modelling predictive approaches. Furthermore, investigators do not have access to as many692 
tools for sheep as for rodents, in particular molecular ones for mechanistic investigations. Finally, for 693 
some endpoints of adverse effects, such as cognitive or behavioural alterations, there are almost no well 694 
standardised tools or validated sheep models for human neurobehavioural abnormalities. 695 
Because of its relevance to human physiology, we conclude that the sheep model and more 696 
generally large animal models can take us one step further for a better understanding of EDs. But 697 
because of their limitations in particular technical ones, those models have to be seen as 698 
complementary to rodent models. Anyway, the best possible models should be used to address 699 
scientific questions and it is our responsibility to question which model/models is/are the most precise 700 
to give the right answers to each specific question for a better understanding and prediction of ED 701 
adverse effects.  702 
  703 
27 
 
FIG. LEGENDS 704 
Fig. 1: Transplacental exchange rates of BPA, BPS and their main glucuronidated metabolites. The % 705 
represent the fraction of a given dose that crosses the placental barrier or the rate at which the parent 706 
molecules are metabolised into glucuronidated conjugates, or, alternatively, the reactivation rate of the 707 
conjugate into native molecules. These data were gen rated in an ovine model of catheterised fetus at a 708 
late gestational stage. 709 
 710 
Fig. 2: Possible interactions of endocrine disruptors with extra-thyroidal metabolism of thyroid 711 
hormones. The thyroid gland synthetises and secretes both T4 and the more biologically active T3. 712 
Thyroid secretion accounts for only 20% of circulating T3. Once in the blood more than 99% of the 713 
TH are bound to proteins. Two of these proteins, thyroid binding globulin (TBG) and transthyretin 714 
(TTR) are of high affinity and specificity. The TH-bound fraction is in equilibrium with the free 715 
hormone fraction, the only accessible one for the liver and the target tissues. Once in the liver, TH can716 
be deiodinated by specific deiodinases (DOIs) or metabolised mainly through conjugation reactions by 717 
UGTs or sulphotranferase enzymes. The expression of these enzymes can be induced following the 718 
activation of xenosensor nuclear receptors (XNRs) thus leading to increased clearance of TH.  719 
 720 
Fig. 3: Pharmacological properties of the two specific binding proteins transthyretin (TTR) and thyroxin 721 
binding globulin (TBG) of thyroid hormones (TH) in both humans and sheep. Kd is the dissociation 722 
constant that characterises the affinity of the protein for T4, the lower Kd, the higher affinity of the 723 
binding proteins for TH. 724 
 725 
Fig. 4: Timelines of fetal thyroid axis maturation and neural development in sheep (Barlow, 1969; 726 
Ferreiro et al., 1987; Fisher, 1991; Fisher et al.,1976; McIntosh et al., 1979; Polk et al., 727 
1991; Thomas et al., 1993), humans (Howdeshell, 2002) and rats (Howdeshell, 2002) from 728 
conception to birth or to PND22 for the rat. Only gobal starting points of the different processes are 729 
indicated, there is no indication about the quantittive changes of the different parameters throughout 730 
fetal development (except for the fetal thyroid function). All these processes keep evolving during 731 
28 
 
subsequent postnatal development. The human and rat elements are adapted from Howdeshell; 732 
2002. 733 
 734 
Fig. 5: Schematic summary of the experimental scheduling sed in the Aberdeen sewage sludge studies. 735 
Days of gestation along the top between “sex determination” and “birth”. Animals were harvested at 80, 736 
110, 140 days of gestation and at 18 months. While t e Windows and Cross-over studies were single 737 
large studies, the Always study where animals were not changed from pre-gestation exposure conditions 738 
(sewage sludge vs control [inorganic] fertiliser) was run several times. 739 
 740 
Fig. 6: Global summary of the findings of the Aberdeen sewage sludge studies. Processed human 741 
sewage sludge pellets were used according to agricultu al guidelines. There was accumulation of EDs in 742 
the soil but only modest changes in maternal and fetal tissue levels of EDs. Nevertheless, extensive 743 
morphological, endocrine, molecular and behavioural consequences for the fetus, some of which have 744 
been shown to persist into adulthood. *personal communication P.A. Fowler, University of Aberdeen, 745 
manuscript in preparation. For references see relevant text. 746 
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Viguié et al., Highlights 
• Endocrine disruption is a very complex and critical public health issue 
• There is a need for human-relevant models to assess endocrine physiology and the 
physiology of period at risks 
• The sheep is a good alternative to classical rodent models to understand fetal 
exposure, thyroid disruption and its consequences on brain development 
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